Japanese researchers trained an AI model to rate atopic dermatitis severity from patient-taken photos, showing 98% ...

Atopic dermatitis manifests differently in patients with darker skin color, according to the companies, including subtler presentations and more severe and prolonged lesions compared to patients with ...

Ivarmacitinib, also known as oral SHR0302, is not yet approved by the FDA, with trials currently exploring its utility in ...

One in every 10 kids in the United States has asthma, a chronic breathing condition that can affect nearly every part of ...

The latest update atopic dermatitis guidelines include the new approval of lebrikizumab and the expanded use of baricitinib and abrocitinib.

Bosakitug is a Potential Best-in-Class Investigational Monoclonal Antibody with Demonstrated Superior Potency, Residence Time ...

Those that know, know: Atopic dermatitis, otherwise known as eczema, is no walk in the park—especially for Black folks. According to the National Eczema Association, African Americans are more likely ...

New data from the Phase 3 INTEGUMENT-OLE long-term open label study show durable improvement in the signs and symptoms of atopic dermatitis (AD), including almost half of participants achieving no or ...